Skip to main content

Positron Corporation

corporate_fare Company Profile

Positron Corporation

POSC·OTC·Industrial Applications And Services·CIK 0000844985

Positron Corporation is a medical technology company that co-develops, manufactures, and sells PET and PET-CT imaging systems. The company delivers molecular imaging solutions to healthcare providers to improve the diagnosis and treatment of cardiovascular disease and other critical conditions. Positron combines proprietary PET and PET-CT systems with clinical and technical support, flexible financing, and a focus on operational efficiency. The company specializes in cardiac PET imaging and has a growing presence in oncology and neurology. Positron's systems are designed to enhance patient outcomes, maximize system uptime, and reduce total cost of ownership. In 2023, Positron entered an expanded business cooperation / OEM Supply and Distribution / SKD Manufacturer Agreement with Shenyang Intelligent Neuclear Medical Technology Co., a subsidiary of Neusoft Medical Systems. This agreement secured exclusive rights for the North American market to sell/distribute PET, PET-CT, and next-generation PET-CT scanners in the future. Positron maintains a primary focus on cardiac PET imaging, which is utilized in nuclear cardiology for the diagnosis and management of cardiovascular disease. The company's imaging portfolio includes its dedicated PET system and its next-generation PET-CT platform. Positron is preparing for the introduction of its Affinity™ PET-CT 4D 64-slice system.

Positron Corporation (OTC:POSC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 7 items for POSC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 7 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for POSC spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • Positron Q3 10-Q: Going Concern Reaffirmed, $550K Stockholders' Deficit, Cash Down to $1.9M
  • Positron Secures $2M in 20% Notes from Affiliates, Adds 400K Warrants
  • Positron Secures $2M Credit Line from Affiliated Investor with Warrants
  • Positron Q2 10-Q: Going Concern Warning as Cash Drops to $357K
  • POSITRON Q1 Revenue Dips 7% to $111K, Narrows Net Loss to $1.38M

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$461.45K
Net Income
-$10.6M
Diluted EPS
-$0.34
Op. Cash Flow
-$4.7M
Gross Profit
-$2.11M
Operating Income
-$10.5M
Cash & Equivalents
$2.52M
Total Debt
$153.69K
Debt / Equity
0.11×
Net Margin
-22.98×
Shares Outstanding
32.8M sh
Source: 10-K · filed 2026-03-31 · accession 0001539497-26-001063

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 1,278 shares in POSC as of the October 30, 2026 settlement, a 387.8% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 22.9% of POSC volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,278 shares as of October 30, 2026
Change vs prior period▲ 387.8%
Days to cover1.00 at avg daily volume of 11,347
Daily short volume (FINRA facilities)22.9% of 28,872 shares on November 20, 2026
5-day average short volume44.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for POSC, detected from its recent SEC filings · based on capital-structure filings through 2026-10-02.

$2M Notes Issued at 20% Interest · 400K New Warrants at $2.00

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with P →
$1.55 -0.96% today
52-week range · as of 2026-11-13 $1.27 – $2.74
Market cap
$52.29M
Volume
29.2K (2.4× avg)
3-mo avg 12.1K
Live data · 2026-11-22 09:58 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed POSC - Latest Insights

POSC
Nov 13, 2026, 5:01 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.64
Real-time Price: $1.55 info
Change: -$0.090 (-5%) info
Market Cap: $52.292M info
POSC
Oct 02, 2026, 4:54 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.77
Real-time Price: $1.55 info
Change: -$0.215 (-12%) info
Market Cap: $52.292M info
POSC
Aug 18, 2026, 4:48 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.81
Real-time Price: $1.55 info
Change: -$0.260 (-14%) info
Market Cap: $52.292M info
POSC
Aug 14, 2026, 5:10 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.81
Real-time Price: $1.55 info
Change: -$0.260366 (-14%) info
Market Cap: $52.292M info
POSC
May 15, 2026, 4:11 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.95
Real-time Price: $1.55 info
Change: -$0.395 (-20%) info
Market Cap: $52.292M info
POSC
May 15, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.95
Real-time Price: $1.55 info
Change: -$0.395 (-20%) info
Market Cap: $52.292M info
POSC
Mar 31, 2026, 2:04 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.72
Real-time Price: $1.55 info
Change: -$0.170 (-10%) info
Market Cap: $52.292M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets